Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 2/10/2025NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
  • 2/10/2025Sunshine Lake Pharma's NS5A Inhibitor Netanasvir Phosphate Approved in...
  • 2/7/2025Toll Biotech Secures FDA and NMPA IND Approvals for TLR8 Modulator Tol...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/5/2025MediLink's YL217 received FDA Clearance of IND Application
  • 2/2/2025FDA Approves Minwei Biotech's IND for MWN105
  • 2/2/2025BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
  • 2/2/2025FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
  • 1/28/2025Akeso's Gumokimab Advances Toward Approval in China for Plaque Psorias...
  • 1/28/2025Chinese Researchers Develop Promising Nanovaccine for Breast Cancer Tr...
  • 1/22/2025Innovent Advances PD-1/IL-2α-Bias Bispecific Antibody IBI363 into Pha...
  • 1/22/2025YolTech to Initiate a Clinical Trial of FIC Bone Marrow-Targeted In V...
  • 1/21/2025NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
  • 1/21/2025CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...
  • 1/21/2025Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China
  • 1/21/2025NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...
  • 1/20/2025NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS
  • 1/20/2025NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...
  • 1/17/2025Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
  • 1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...
  • 1/15/2025Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
  • 1/15/2025Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
  • 1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
  • 1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection
  • 1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
  • 1/13/2025Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
  • 1/13/2025J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
  • 1/13/2025Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
  • 1/12/2025WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
  • 1/11/2025Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...
  • Page:9/15 Total number of articles:433: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group